Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver

2014 ◽  
Vol 110 (8) ◽  
pp. 976-981 ◽  
Author(s):  
Jong Man Kim ◽  
Choon Hyuck David Kwon ◽  
Jae-Won Joh ◽  
Jae Berm Park ◽  
Joon Hyeok Lee ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Cirrhotic Liver ◽  
B Virus ◽  
Curative Hepatectomy

Prognosis After Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma Originating from Non-cirrhotic Liver

2014 ◽  
Vol 21 (7) ◽  
pp. 2406-2412 ◽  
Author(s):  
Yan-Ming Zhou ◽  
Xiao-Feng Zhang ◽  
Bin Li ◽  
Cheng-Jun Sui ◽  
Jia-Mei Yang
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Cirrhotic Liver ◽  
B Virus

scholarly journals A Novel Blood Index-Based Model to Predict Hepatitis B Virus-Associated Hepatocellular Carcinoma Recurrence After Curative Hepatectomy: Guidance on Adjuvant Transcatheter Arterial Chemoembolization Choice

2021 ◽  
Vol 11 ◽  
Author(s):  
Yiping Zou ◽  
Zhihong Chen ◽  
Qi Lou ◽  
Hongwei Han ◽  
Yuanpeng Zhang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Transcatheter Arterial Chemoembolization ◽  
Recurrence Risk ◽  
Blood Index ◽  
B Virus ◽  
Hcc Recurrence ◽  
Curative Hepatectomy ◽  
Arterial Chemoembolization

BackgroundPostoperative recurrence is a significant obstacle in hepatocellular carcinoma (HCC) treatment. This study aimed to construct a blood index-based model to predict hepatitis B virus-associated HCC (HBV-HCC) recurrence after curative hepatectomy.MethodsA total of 370 patients who received initially curative hepatectomy for HBV-HCC were included in this study. A novel blood index signature (BIS) was identified and systematically analyzed for its recurrence predictive value. Following this, multivariate Cox regression analysis was performed to build a blood index-based nomogram.ResultsA BIS based on the aminotransferase-to-platelet ratio index and a systemic inflammatory response index was used to construct a nomogram. The model showed good clinical applicability and reliability. Notably, the patients in the high recurrence risk group tended to benefit from adjuvant transcatheter arterial chemoembolization (TACE).ConclusionA reliable model was constructed to predict the HBV-HCC recurrence after curative hepatectomy. This model can guide the surgeons in selecting patients with high recurrence risk patients who may benefit from adjuvant TACE.

Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver

1991 ◽  
Vol 12 (1) ◽  
pp. 54-59 ◽  
Author(s):  
C. Kalayci ◽  
P.J. Johnson ◽  
S.E. Davies ◽  
Roger Williams
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Cirrhotic Liver ◽  
B Virus
Sign in / Sign up

Export Citation Format

Share Document